// App-Quantinova.ai

P061 : Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course

Researchers

Presenter

  • Heredia, M

Principal Investigators

  • Charrout, M

  • Klomberg, R.C.W

  • Aardoom, M.A

  • Jongsma, M.M.E

  • Kemos, P

  • van Haaften, D.H

  • Tuk, B

  • van Berkel, L.A

  • Bley Folly, B

  • Mahfouz, A

  • Reinders, M.J.T

  • Ruemmele, F

  • Croft, N

  • Escher, J.C

  • de Ridder, L

  • Samsom, J.N

Medical Centers

  • Erasmus University Medical Center‐Sophia Children's Hospital, Dept. of Pediatric Hematology, Rotterdam, the Netherlands

  • Delft University of Technology, Delft Bioinformatics Lab, Delft, The Netherlands

  • Erasmus University Medical Center‐Sophia Children's Hospital, Dept. of Pediatric Hematology, Rotterdam, the Netherlands

  • Blizard Institute, Queen Mary University of London, Centre for Immunology and Infectious Disease, London, United Kingdom

  • Leiden University Medical Center, Department of Immunology, Leiden, Netherlands

  • Hôpital Necker-Enfants Malades- Institut Imagine- AP-HP- Université de Paris, Pediatric Gastroenterology, Paris, France

Locations

  • Netherlands

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A